Drug Type Small molecule drug |
Synonyms D24 |
Target |
Action antagonists |
Mechanism ERα antagonists(Estrogen receptor alpha antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H27F3N2O2 |
InChIKeyXKYAKCQZMYWSSE-CHAGWJKLSA-N |
CAS Registry2235396-63-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Estrogen receptor positive breast cancer | Preclinical | China | 31 May 2021 |





